medable

About

Medable is the leading technology platform for agentic AI-powered clinical development, transforming how clinical trials are conducted globally. Founded in 2015 by Dr. Michelle Longmire, a physician-scientist who experienced firsthand the challenges of patient access in clinical research, Medable has built an end-to-end cloud-based platform that enables pharmaceutical sponsors, contract research organizations (CROs), healthcare providers, and patients to collaborate seamlessly in clinical trials. The company provides a comprehensive suite of tools including electronic Clinical Outcome Assessment (eCOA), decentralized clinical trial solutions, AI-powered agent platforms, and study management tools. Medable's platform allows sponsors to build studies up to 35 times faster with their Studio and AI technology, reducing trial timelines significantly. The company serves mid-to-large pharmaceutical companies, emerging biotech firms, and CROs across therapeutic areas such as oncology and vaccines. Medable's mission is to get effective therapies to patients faster, with a bold vision of achieving 1-day study startup, 1-day patient enrollment, and 1-year study conduct timelines. The company has earned recognition including Everest Group Leader status for DCT and eCOA solutions, as well as Prix Galien awards for Best Digital Platform. Committed to global regulatory compliance, Medable maintains certifications for HIPAA, GDPR, ISO, FDA 21 CFR Part 11, and ICH E6(R2) GCP standards.